Jonah Comstock

September 18, 2017
Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by delivering neurostimulation at the spinal cord. Using a Samsung Galaxy Tab S2, the patient's caregiver can adjust the neurostimulation according to a workflow designed by Medtronic called Evolve. "Drawing...
September 18, 2017
A new study of 120 sports medicine patients shows that telemedicine saved patients an average of $50 in travel costs and 51 minutes in waiting and visit time, and saved a health system $24 per patient. The study, which has not yet been published, was presented last week at American Academy of Pediatrics National Conference and Exhibition. It was conducted by Nemours Health System. "We know that...
September 15, 2017
A brain-training video game shows promising signs for the treatment of ADHD in a new randomized clinical trial. In the game, from developer NeuroPlus, children wear an EEG monitor and additional sensors that measure movement and muscle tension. The readings from those sensors actually control the game — in one game, the player rides a dragon that speeds up the more they focus and slows down when...
September 15, 2017
One of the biggest promises of mobile health apps and wearables is the sheer amount of data they collect. As that dataset grows, a number of different stakeholders are taking an interest in it, among them patients themselves, doctors, and clinical researchers. The latter is the focus of a new report out today from the Duke-Margolis Center for Health Policy. “Under a collaborative agreement with...
September 14, 2017
Brooklyn-based Call9 has raised $24 million in a new round of funding. Redmile led the round, with additional investments from Index Ventures, Refactor, YCombinator, Western Technology Investments, and other undisclosed investors. This is the second round of funding for the company, which raised $10 million in January 2016. The new funding will be used to scale Call9’s operations. Call9's video...
September 14, 2017
In an FDA first, Boston- and San Francisco-based Pear Therapeutics' reSET system for the treatment of substance abuse has been granted a de novo clearance by the agency. It's the first software-only digital therapeutic the FDA has cleared with claims to improve clinical outcomes in a disease. “This is a defining moment for digital therapeutics and for patients with substance use disorder,” Corey...
September 14, 2017
In an increasingly common transition from the consumer tech world to health tech, former Spotify VP of Product Dave Rodger has moved over to Boston-based care coordination tech company PatientPing.  “I feel strongly that healthcare providers should enjoy as high-quality an experience at work with technology as we do in our personal lives on our smartphone and web apps," PatientPing CEO Jay Desai...
September 13, 2017
Today was a big day in the world of diabetes management technology, with major announcements from Abbott, Livongo, and Senseonics. Read on below for a round-up of diabetes news. Livongo acquires Diabeto Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management...
September 13, 2017
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed. Though it was founded in 2012, Diabeto really hit the scene in 2015 with an...
September 13, 2017
Dr. David Brailer may be best known as the first ever National Coordinator for Health Information Technology. But Brailer has held a diverse range of roles before and since that give him a uniquely well-rounded perspective on digital health. “I’m a physician,” Brailer told MobiHealthNews in a recent interview. “I’m a PhD economist, but spent most of my career as an entrepreneur in the digital...